UBS Group’s Covisint Corporation COVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-11,708
| Closed | -$29K | – | 8341 |
|
|
2017
Q2 | $29K | Buy |
11,708
+474
| +4% | +$990 | ﹤0.01% | 6043 |
|
|
2017
Q1 | $23K | Sell |
11,234
-5
| -0% | -$10 | ﹤0.01% | 6060 |
|
|
2016
Q4 | $21K | Sell |
11,239
-4,224
| -27% | -$9.11K | ﹤0.01% | 6497 |
|
|
2016
Q3 | $34K | Buy |
15,463
+4,084
| +36% | +$8.92K | ﹤0.01% | 5827 |
|
|
2016
Q2 | $25K | Sell |
11,379
-6,872
| -38% | -$13.3K | ﹤0.01% | 6132 |
|
|
2016
Q1 | $37K | Buy |
18,251
+6,844
| +60% | +$13.9K | ﹤0.01% | 5734 |
|
|
2015
Q4 | $29K | Sell |
11,407
-2,788
| -20% | -$6.31K | ﹤0.01% | 6380 |
|
|
2015
Q3 | $30K | Buy |
14,195
+2,211
| +18% | +$6.08K | ﹤0.01% | 6304 |
|
|
2015
Q2 | $39K | Buy |
11,984
+11,003
| +1,122% | +$26.1K | ﹤0.01% | 6230 |
|
|
2015
Q1 | $2K | Sell |
981
-91,777
| -99% | -$214K | ﹤0.01% | 8500 |
|
|
2014
Q4 | $246K | Buy |
+92,758
| New | +$266K | ﹤0.01% | 4839 |
|
UBS Group's COVS Position: Q3 2017 in Review
UBS Group sold out of Covisint Corporation (COVS) in Q3 2017, closing a stake of 11,708 shares — an estimated $29K sold.
UBS Group first reported a position in COVS in Q4 2014 and held it in 11 quarters. The position peaked at $246K in Q4 2014. 0 funds tracked by Wall St. Rank hold COVS as of Q3 2017.
- UBS Group reported no remaining Covisint Corporation position as of Q3 2017 after selling out during the quarter.
- UBS Group sold 11,708 Covisint Corporation shares in Q3 2017, an estimated $29K.
- UBS Group first reported a position in Covisint Corporation in Q4 2014 and held it in 11 quarters.
- UBS Group's Covisint Corporation position peaked at $246K in Q4 2014.
- 0 funds tracked by Wall St. Rank held Covisint Corporation as of Q3 2017.
Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.